Acquired CFTR dysfunction and dense distribution of ionocytes in nasal mucosa of children with CRS

Yang Han1, Chao Jia2, Tieshan Wang3

  • 1Department of Otolaryngology, Head and Neck Surgery, National Center for Children's Health, Beijing Children's Hospital, Capital Medical University, 56 NanLishi Road, Xicheng District, Beijing, 100045, China.

Insights

Children with chronic rhinosinusitis (CRS) have fewer ionocytes and reduced cystic fibrosis transmembrane conductance regulator (CFTR) function in their nasal lining. Inflammation impacts ionocyte distribution and CFTR expression, potentially linking to polyp development.

Area of Science:

  • Respiratory Medicine
  • Cell Biology
  • Pediatric Otolaryngology

Background:

  • Ionocytes are specialized airway epithelial cells with high expression of the cystic fibrosis transmembrane conductance regulator (CFTR).
  • Understanding ionocyte and CFTR roles is crucial for airway diseases.

Purpose of the Study:

  • To investigate ionocyte morphology, distribution, and CFTR function in pediatric nasal mucosa.
  • To examine these factors in children with chronic rhinosinusitis with nasal polyps (CRSwNP).

Main Methods:

  • Flow cytometry analyzed ionocyte numbers and CFTR function in exfoliated nasal cells from 101 children.
  • RNAscope identified FOXI1 and CFTR expression in nasal mucosa and polyp tissues from 10 CRSwNP patients.

Main Results:

  • CRS patients exhibited fewer ionocytes and decreased CFTR function.
  • CFTR expression in CRS nasal mucosa was focally dense and increased with inflammation.
  • Ionocytes in nasal polyps often lacked CFTR expression and typical morphology.

Conclusions:

  • Reduced ionocyte numbers and impaired CFTR function are observed in pediatric CRS.
  • Inflammation influences ionocyte and CFTR distribution.
  • Loss of CFTR expression and altered ionocyte shape may contribute to nasal polyp formation.
Abstract

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
323
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
209
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.8K